https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Among 10 patients with various autoimmune diseases who had failed numerous conventional treatments, nine saw substantial improvement with the multiple myeloma drug teclistamab (Tecvayli), researchers said.
Three of the patients…
